Mentor Capital Inc.

66 Days Left on $1 Call

About Mentor Capital About MNTR Summary Data Management Team Professional Support Philosophy Ethics Corporate Governance The Investor's Corner 2009 Annual Financials (Subject to Audit Adjustments) 2008 Audit 15(c) 2-11 Analysts' Coverage $5 / Share - Sr. Securities Analyst Cancer Imm Index Information Visit Portfolio Companies

Trading Chart

QI Proxy Contest Links

Charles Broes & John Stanton
Charles Broes & John Stanton (61 hits)
Charles Broes & John D Stanton (3 hits)
Chuck Broes & John Stanton (37 hits)
Chuck Broes & John D Stanton (4 hits)
Charles Broes & Alexander Edwards
Charles Broes & Alex Edwards (8 hits)
Chuck Broes & Alex Edwards (5 hits)
Charles Broes & Alexander Edwards (7 hits)
Chuck Broes & Alexander Edwards (4 hits)
Charles Broes & Alexander Edwards+III (2 hits)
Chuck Broes & Alexander Edwards+III (4 hits)
- John Stanton & Alexander Edwards
  John Stanton & Alex Edwards (96 hits)
  John D+Stanton & Alex Edwards (399 hits)
  John Stanton & Alexander Edwards (110 hits)
  John D Stanton & Alexander Edwards (313 hits)
  John Stanton & Alexander Edwards+III (9 hits)
  John D Stanton & Alexander Edwards+III (195 hits)
- John Stanton & SEC Investigation
  John Stanton & SEC Investigation (106 hits)
  John D Stanton & SEC Investigation (5 hits)
- Alexander Edwards & SEC Investigation
  Alex Edwards & SEC Investigation (7 hits)
  Alexander Edwards & SEC Investigation (94 hits)
Charles Broes & J Morton Davis
J Morton Davis & Charles Broes (4 hits)
Charles Broes & June Nichols
June Nichols & Chuck Broes (72 hits)
June Sweeney & Chuck Broes (1 hits)
June Nichols & Charles Broes (7 hits)
Charles Broes & David Hood
David Hood & Chuck Broes (73 hits)
David Hood & Charles Broes (9 hits)
- David Hood & SEC Investigation
  David Hood & SEC Investigation (5 hits)
Charles Broes & David Bryant
David Bryant & Chuck Broes (3 hits)
David Bryant & +Charles Broes (6 hits)
- David Bryant & SEC Investigation
  David Bryant & SEC Investigation (5 hits)
- Chuck Broes & June Nichols & David Hood
  June Nichols & David Hood & Chuck Broes (69 hits)
  June Nichols & David Hood & Charles Broes (3 hits)
- Chuck Broes & June Nichols & David Bryant
  June Nichols & David Bryant & Chuck Broes (3 hits)
  June Nichols & David Bryant & Charles Broes (4 hits)
- Chuck Broes & David Bryant & David Hood
  David Bryant & David Hood & Chuck Broes (3 hits)
  David Bryant & David Hood & Charles Broes (4 hits)
- June Nichols & David Bryant & David Hood
  David Bryant & David Hood & June Nichols (5 hits)
- Chuck Broes & June Nichols & David Bryant & David Hood
  David Bryant & David Hood & June Nichols & Chuck Broes (3 hits)
  David Bryant & DavidHood & June Nichols &Charles Broes (1 hit)
Charles Broes & Mark Clancy
Mark Clancy & Charles Broes (33 hits)
- Mark Clancy & SEC Investigation
  Mark Clancy & SEC Investigation (2 hits)
  
  Mark Clancy & John Stanton (481 hits)
  Mark Clancy & Alexander Edwards (8 hits)
  Mark Clancy & June Nichols (7 hits)
  Mark Clancy & David Hood (19 hits)
  Mark Clancy & David Bryant (9 hits)

Charles Broes & Entellectual Solutions Property Group
Entellectual & Charles Broes (5 hits)
ESPG & Charles Broes (9 hits)
Charles Broes & EliteCorp
EliteCorp & Charles Broes (30 hits)
EliteCorp & Chuck Broes (94 hits)
Taina Broes
David Bryant & Taina Broes (2 hits)
David Hood & Taina Broes (3 hits)
John Stanton & Taina Broes (7 hits)
Alexander Edwards & Taina Broes (2 hits)

TB of Tampa, LLC
TB of Tampa (3 hits)
TB of Tampa & Chuck Broes (3 hits)
TB of Tampa & Charles Broes (6 hits)
TB LLC & Chuck Broes (1 hit)
TB LLC & Charles Broes (1 hit)

The Mentor Capital Cancer Immunotherapy Index^©

Our Science Explained

For Email Marketing you can trust

Site Search

Home

Changing Assets & Acquisitions

QI Information

Chairman's Letters

◦	Welcome to the Team Leading the Cancer Fight

Press Releases

◦	List of All Releases
◦	Mentor Capital Extends Funding to Leading-Edge Cancer Therapy Companies
◦	Nobel Laureate Reinforces the Mentor Capital Strategy to Fund Only Leading-edge Cancer Science
◦	Mentor Capital Cancer Immunotherapy Index Gains on Medicare Advisory Committee Approval
◦	MNTR Sees Shift To Public Acceptance
◦	Cancer Index at New High with 12 Yr Exclusive Period in Health Bill
◦	Provectus Pharmaceuticals (PVCT) added to Cancer Immunotherapy Index.
◦	MNTR Invests in 10 Cancer Index Companies
◦	MNTR Retains Investment Bank to Assist Roll Out Cancer Immunotherapy Index Fund
◦	2010 Actively Managed Cancer Immunotherapy Index Announced by MNTR
◦	University Agreement Indicates Broad Cancer Application for QI Treatment
◦	New Lab, Filings and JV Talks
◦	MNTR Presents In NYC
◦	Start of FDA Trials
◦	QI Announces MNTR
◦	MNTR Acquires First 20% of QI
◦	MNTR Calls $3 Million Tranche
◦	MNTR Initiates Trading

Cancer Resources

Information For Brokers

Shareholder Updates

FAQ

All PDF documents will open a new browser window

Safe Harbor Statement Site Map